Please ensure Javascript is enabled for purposes of website accessibility

Why Onconova Therapeutics Stock Soared Today

By Joe Tenebruso - Feb 17, 2021 at 5:51PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are eager to hear more about the biotech's experimental cancer treatments.

What happened

Shares of Onconova Therapeutics (ONTX 2.40%) surged 23.8% on Wednesday, bringing the biopharmaceutical company's year-to-date gains to an impressive 245%.  

So what

Onconova announced after the market close on Tuesday that it raised $28.75 million via a stock offering. The biotech sold 28.75 million shares at a price of $1.00 per share. The proceeds from the stock sale should help to shore up Onconova's balance sheet and give it more of the cash it needs to fund its cancer-treatment development programs. 

A person is pointing to an upwardly sloping line.

Onconova Therapeutics' stock price rose sharply on Wednesday. Image source: Getty Images.

Investors are also awaiting news from the 2021 BIO CEO & Investor Digital Conference, which began on Feb. 16 and is scheduled to end on Feb. 18. Onconova CEO Steven Fruchtman is presenting at the conference, while Senior Vice President Avi Oler will be conducting meetings with potential development and investment partners. Onconova said it would make Fruchtman's presentation available on its website on Feb. 19. 

Now what 

Onconova is dedicated to developing new treatments for people with cancer. Its efforts are focused on disrupting key cellular pathways that play a role in cancer cell growth. Its treatment candidates are currently in early-stage trials. 

Onconova is operating in a potentially massive market that is also intensely competitive. Thus, its stock is a relatively risky investment, albeit one with considerable upside potential.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Onconova Therapeutics, Inc. Stock Quote
Onconova Therapeutics, Inc.
$1.28 (2.40%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.